Controlled release formulations

Details for Australian Patent Application No. 2004245029 (hide)

Owner Alpharma, Inc

Inventors Vilkov, Zalman

Agent Fisher Adams Kelly

Pub. Number AU-B-2004245029

PCT Pub. Number WO2004/108082

Priority 10/452,754 02.06.03 US

Filing date 2 June 2004

Wipo publication date 16 December 2004

Acceptance publication date 30 August 2007

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/108082 Priority application(s): WO2004/108082

30 August 2007 Application Accepted

  Published as AU-B-2004245029

3 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245030-Method and devices for performing cardiac waveform appraisal

2004245028-Drug delivery device and method for bidirectional drug delivery